Intuitive Surgical Accounts Receivable increased by 4.5% to $1.60B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 30.6%, from $1.22B to $1.60B. Over 5 years (FY 2020 to FY 2025), Accounts Receivable shows an upward trend with a 18.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to sales may signal collection issues or a shift in customer payment terms, while a decrease indicates efficient cash conversion.
This represents the balance of money owed to the company by customers for goods or services delivered, adjusted for an a...
Varies by industry, but generally benchmarked against Days Sales Outstanding (DSO) for peer medical device companies.
accounts_receivable_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $699.90M | $695.00M | $782.70M | $906.10M | $838.50M | $849.60M | $942.10M | $925.30M | $904.20M | $962.70M | $1.13B | $1.13B | $1.11B | $1.15B | $1.23B | $1.22B | $1.27B | $1.26B | $1.53B | $1.60B |
| QoQ Change | — | -0.7% | +12.6% | +15.8% | -7.5% | +1.3% | +10.9% | -1.8% | -2.3% | +6.5% | +17.4% | -0.2% | -1.7% | +4.0% | +6.3% | -0.3% | +3.9% | -0.7% | +21.2% | +4.5% |
| YoY Change | — | — | — | — | +19.8% | +22.2% | +20.4% | +2.1% | +7.8% | +13.3% | +20.0% | +21.9% | +22.7% | +19.8% | +8.4% | +8.3% | +14.4% | +9.3% | +24.6% | +30.6% |